logo-loader

Lexaria Bioscience announces partnership with U.S. giant Altria to fund R&D

Published: 15:06 15 Jan 2019 EST

Lexaria Bioscience (CSE:LXX-OTCQX:LXRP) CEO Chris Bunka joined Steve Darling from Proactive Investors Vancouver to talk about Lexaria's new partnership with U.S. tobacco giant Altria.

Altria will fund a milestone-based research & development program in exchange for a minority equity interest in Lexaria Nicotine. Altria will provide initial funding of US$1 million, with the option for additional funding of up to US$12 million.

Lexaria Bioscience Revolutionizes Drug Delivery with DehydraTECH for GLP-1 drug

Lexaria BioScience CEO Chris Bunka joined Steve Darling from Proactive to share significant updates regarding its focus on DehydraTECH, a patented drug delivery formulation and processing platform technology aimed at improving the oral delivery of active pharmaceutical ingredients. Lexaria...

1 week, 3 days ago